Early Death May Be Common in Cancer Patients Taking Immune Checkpoint Inhibitors
Results of a real-world study suggest that early death may be common among cancer patients taking immune checkpoint inhibitors.
Diagnosis & Disease Information
Bladder Cancer Linked to Occupational Solvent Exposure
As cumulative occupational exposure to benzene-toluene-zylene increases, so does the risk for bladder cancer, new data suggest.
Urothelial Cancer Prediction Model Has High Sensitivity, Specificity
Model, which considers 10 genes from UroAmp uCGP test, had high sensitivity and specificity in two validation cohorts.
Radical Cystectomy Increases Risks for Thromboembolic Events
Swedish studies reveal significantly elevated risks for myocardial infarction, ischemic stroke, pulmonary embolism, and deep vein thrombosis.
Survival Improving in Metastatic Bladder Cancer Cases
Trend may reflect increasing use of systemic immunotherapies as first-line treatments, according to investigators.
Gemcitabine, Docetaxel a Viable Alternative to BCG in Bladder Cancer
Less high-grade disease recurrence and lower treatment discontinuation seen with gemcitabine and docetaxel versus bacillus Calmette-Guérin.
Cancer Patients May Be Treated With Drugs That Provide No Benefit
Many cancer patients may be treated with drugs that were granted accelerated approval but do not provide a clinical benefit, a study suggests.
Improving Patient-Centered Care After Urinary Diversion
This report reviews the challenges patients with bladder cancer experience related to cystectomy and urinary diversion surgery.
Neoadjuvant Pembrolizumab Shows Promise for Cisplatin-Ineligible MIBC
There is an unmet need for systemic treatment options in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based neoadjuvant chemotherapy, according to investigators.
Neoadjuvant Chemo Predicts Better Survival in Node Positive UTUC
Receipt of neoadjuvant vs adjuvant chemotherapy did not differ significantly by clinical nodal stage.
- Loading...
Loading...
Next post in Genitourinary Cancer
Loading... 
Loading...